Acute Kidney Injury Clinical Trial
Official title:
Neutral Endopeptidase for Early Detection of Acute Kidney Injury After Cardiac Surgery
The investigators want to investigate if the urinary biomarker neprilysin can identify cardiac surgical patients suffering from postoperative AKI within 24 hours.
Acute kidney injury (AKI) is a common complication following cardiac surgery and
significantly increases morbidity, duration of hospital stay, and mortality. The diagnosis of
AKI relies on changes in serum creatinine (SCr) from a baseline value or decreases in urine
output. Nevertheless changes of SCr to diagnose AKI are only reliable after a minimum of 48
hours.
Neutral endopeptidase, also called neprilysin (NEP) represents a single-pass membrane
glycoprotein with zinc-dependent endopeptidase activity and a short cytosolic tail and is
found in epithelia, fibroblasts, and neutrophils and in soluble form in the circulation,
urine, and cerebrospinal fluid. Beside the focus of interest in cardiovascular medicine for
its role in heart failure, where the inhibition of NEP by the administration of
sacubitril/valsartan may achieve an improvement in patients with chronic heart failure and
reduced ejection fraction, there is also thought to be a link to renal damage.
NEP is expressed in the brush border of proximal tubular cells, which is first shed in renal
damage and therefore it is a marker for tubular damage when it is measurable in urine In this
study the investigators want to investigate if NEP is a marker for earlier detection of AKI
after elective cardiac surgery compared to the currently recommended Kidney Disease -
Improved Global Outcomes (KDIGO) guidelines for acute kidney injury. Also, the investigators
want to investigate at predefined time points the occurrence and the progression of tubular
damage during cardio-pulmonary bypass (CPB) in a closed-meshed NEP detection.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05538351 -
A Study to Support the Development of the Enhanced Fluid Assessment Tool for Patients With Acute Kidney Injury
|
||
| Recruiting |
NCT06027788 -
CTSN Embolic Protection Trial
|
N/A | |
| Completed |
NCT03938038 -
Guidance of Ultrasound in Intensive Care to Direct Euvolemia
|
N/A | |
| Recruiting |
NCT05805709 -
A Patient-centered Trial of a Process-of-care Intervention in Hospitalized AKI Patients: the COPE-AKI Trial
|
N/A | |
| Recruiting |
NCT05318196 -
Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases
|
||
| Recruiting |
NCT05897840 -
Continuous Central Venous Oxygen Saturation Measurement as a Tool to Predict Hemodynamic Instability Related to Renal Replacement Therapy in Critically Ill Patients
|
N/A | |
| Recruiting |
NCT04986137 -
Fractional Excretion of Urea for the Differential Diagnosis of Acute Kidney Injury in Cirrhosis
|
||
| Terminated |
NCT04293744 -
Acute Kidney Injury After Cardiac Surgery
|
N/A | |
| Completed |
NCT04095143 -
Ultrasound Markers of Organ Congestion in Severe Acute Kidney Injury
|
||
| Not yet recruiting |
NCT06026592 -
Detection of Plasma DNA of Renal Origin in Kidney Transplant Patients
|
||
| Not yet recruiting |
NCT06064305 -
Transcriptional and Proteomic Analysis of Acute Kidney Injury
|
||
| Terminated |
NCT03438877 -
Intensive Versus Regular Dosage For PD In AKI.
|
N/A | |
| Terminated |
NCT03305549 -
Recovery After Dialysis-Requiring Acute Kidney Injury
|
N/A | |
| Completed |
NCT05990660 -
Renal Assist Device (RAD) for Patients With Renal Insufficiency Undergoing Cardiac Surgery
|
N/A | |
| Completed |
NCT04062994 -
A Clinical Decision Support Trial to Reduce Intraoperative Hypotension
|
||
| Terminated |
NCT02860130 -
Clinical Evaluation of Use of Prismocitrate 18 in Patients Undergoing Acute Continuous Renal Replacement Therapy (CRRT)
|
Phase 3 | |
| Completed |
NCT06000098 -
Consol Time and Acute Kidney Injury in Robotic-assisted Prostatectomy
|
||
| Not yet recruiting |
NCT05548725 -
Relation Between Acute Kidney Injury and Mineral Bone Disease
|
||
| Completed |
NCT02665377 -
Prevention of Akute Kidney Injury, Hearttransplant, ANP
|
Phase 3 | |
| Terminated |
NCT03539861 -
Immunomodulatory Biomimetic Device to Treat Myocardial Stunning in End-stage Renal Disease Patients
|
N/A |